Jason R Brown

19PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 26, 2026
External validation of the NADIR model for early prostate-specific antigen response prediction in enzalutamide-treated metastatic hormone-sensitive prostate cancer: An analysis of the ARCHES trial.

|May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma.

|Feb 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer.

Abby L Grier, Jeffrey Y Zhong, Spyridon Basourakos

|Feb 09, 2026
Immune checkpoint inhibitors in urothelial carcinoma: a practical framework for patient selection, toxicity management, response assessment, and treatment sequencing.

Abdul Rahman Al Armashi, Jenny Gong, Pedro Barata

|Dec 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.

Georges Gebrael, Neeraj Agarwal, Alicia K Morgans

|Dec 09, 2025
Toward a better pan-tumor predictive signature for unleashing precision immuno-oncology.

Jason R Brown, Guru Sonpavde

Pageof 4

Frequent Collaborators

6 joint publications

Albert Jang

5 joint publications

Pedro C Barata

4 joint publications

Laura Bukavina

3 joint publications

Angela Y Jia